Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Endocrinology · 46,XX Testicular DSD

How Does 46,XX Testicular DSD Affect Final Adult Height?

At a Glance

People with 46,XX testicular DSD are often shorter on average than typical 46,XY males and taller than typical 46,XX females, but diagnosis alone cannot predict final height. Family genetics, bone age, pubertal hormones, and growth-plate timing are more informative.

Yes, having 46,XX testicular DSD (sometimes referred to in older medical literature as XX male syndrome) can influence final adult height. Because individuals with this condition usually lack a full Y chromosome, their final adult height is typically shorter than the average typical 46,XY male, but often taller than the average typical 46,XX female.

While these population averages provide a helpful baseline to answer questions about expectations, human stature is highly complex. There is no validated mathematical formula or single height prediction based purely on your diagnosis. Your final adult height will be unique to you and influenced by your family genetics, bone age, and pubertal hormone levels [1].

The Role of Genetics and the Y Chromosome

The Y chromosome contains specific genetic sequences that contribute to overall adult height [2] [3]. In 46,XX testicular DSD, the absence of these Y-specific growth sequences is one reason why medical literature notes that affected men are often shorter relative to the general 46,XY male population [1] [4].

When discussing genetics, it is helpful to understand a few key factors:

  • The SRY Gene: In the most common form of 46,XX testicular DSD, the SRY gene (the gene responsible for initiating typical male testicular development) is present and has usually been transferred to one of the X chromosomes [2]. However, some individuals are SRY-negative, meaning their condition is caused by entirely different genetic pathways [5]. While the SRY gene initiates physical development, it does not independently determine how tall you will grow.
  • The SHOX Gene: The SHOX gene is essential for healthy bone growth. Because this gene is located in a pseudoautosomal region shared by both X and Y chromosomes, a typical 46,XX person has two functional copies of this gene, just like a typical 46,XY person. However, if a structural rearrangement of the chromosomes disrupts or deletes the SHOX gene, it can lead to unexpectedly short stature [6].
  • Family Genetics: Just like anyone else, one of the most reliable predictors of your potential height is the height of your biological parents.

Hormones, Puberty, and Growth Plates

Hormones play a critical role during the teenage growth spurt. Both testosterone and estrogen—much of which is naturally created by the body converting testosterone into estrogen—are vital for growth and for eventually signaling the growth plates in your bones to close. Once growth plates fuse, a person’s height is final.

Many individuals with 46,XX testicular DSD develop hypergonadotropic hypogonadism during or after puberty [7] [8]. This is a clinical condition where the testes do not produce enough testosterone on their own, causing the pituitary gland in the brain to produce higher levels of signaling hormones (LH and FSH) to compensate [8].

If your body is not producing sufficient testosterone, an endocrinologist may recommend testosterone replacement therapy (TRT) [7] [9]. If TRT is discussed, it is important to know:

  • TRT is prescribed primarily to support healthy pubertal development, sexual function, bone health, and overall well-being—not as a guaranteed way to increase final height [9].
  • The timing and dose of TRT must be carefully managed with a specialist. Early or excessive testosterone exposure can prematurely advance bone maturation (closing the growth plates early), while delayed treatment can alter the typical timing of puberty [7].
  • TRT will not lengthen bones after the growth plates have already fused.

Uncertainty about physical development can be incredibly stressful for teens and their parents. Your multidisciplinary care team will monitor your growth velocity and bone age to ensure that any hormone therapy supports your healthiest possible outcome.

Common questions in this guide

What height can I expect if I have 46,XX testicular DSD?
On average, people with 46,XX testicular DSD are shorter than typical 46,XY males but taller than typical 46,XX females. These are population patterns, not a personal height prediction; family genetics, bone age, hormone levels, and growth-plate status can change the outcome.
Can my diagnosis alone predict how tall I will be?
No. There is no validated formula that predicts final height from 46,XX testicular DSD alone. An endocrinologist may consider biological parents' heights, your growth curve, bone age, pubertal stage, and hormone levels.
What does a bone-age X-ray show about my remaining growth?
A bone-age X-ray helps estimate how mature the bones are and whether growth plates remain open. Open plates indicate potential for more height, while fused plates mean height is generally final; clinicians interpret the result alongside growth rate and hormone levels.
Can testosterone replacement therapy increase my final height?
Testosterone replacement therapy is primarily used to support pubertal development, sexual function, bone health, and well-being, not as a guaranteed height treatment. Its timing and dose need specialist oversight because early or excessive exposure can advance bone maturation, and it cannot lengthen bones after growth plates fuse.
Does SRY status determine adult height in 46,XX testicular DSD?
SRY usually initiates testicular development in the most common form, but it does not independently determine height. SRY-positive and SRY-negative results may help explain differences in physical development, while family genetics, Y-linked growth sequences, SHOX changes, hormones, and bone age also matter.
Which hormone tests are relevant when growth or puberty is a concern?
Clinicians may review LH, FSH, testosterone, and estradiol, along with growth rate and bone age. These results help an endocrinology team decide whether hormone support is needed and how it should be managed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my (or my child's) specific diagnosis SRY-positive or SRY-negative, and how might that influence expectations for physical development?
  2. 2.Are the growth plates still open, and what does a recent 'bone age' x-ray suggest about my remaining growth potential?
  3. 3.What are my current LH, FSH, testosterone, and estradiol levels, and do they indicate a need for hormone support?
  4. 4.If testosterone replacement therapy is recommended, how will the dose be managed to support healthy puberty without closing the growth plates too early?
  5. 5.Based on my biological parents' heights, pubertal stage, and my current growth curve, what is my estimated target height range?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Evidence for high breakpoint variability in 46, XX, SRY-positive testicular disorder and frequent ARSE deletion that may be associated with short stature.

    Capron C, Januel L, Vieville G, et al.

    Andrology 2022; (10(8)):1625-1631 doi:10.1111/andr.13279.

    PMID: 36026611
  2. 2

    [Genetic and clinical characteristics of 46,XX testicular disorders of sex development].

    Ye QL, Fang JZ, Yang XY

    Zhonghua nan ke xue = National journal of andrology 2024; (30(2)):118-122.

    PMID: 39177343
  3. 3

    Integration of long-read sequencing, DNA methylation and gene expression reveals heterogeneity in Y chromosome segment lengths in phenotypic males with 46,XX testicular disorder/difference of sex development.

    Berglund A, Johannsen EB, Skakkebæk A, et al.

    Biology of sex differences 2024; (15(1)):77 doi:10.1186/s13293-024-00654-8.

    PMID: 39380113
  4. 4

    46,XX Testicular Disorder of Sex Development (DSD) Presenting With Male Hypogonadism.

    Chin RT, Mok SF

    JCEM case reports 2025; (3(2)):luae237 doi:10.1210/jcemcr/luae237.

    PMID: 39906899
  5. 5

    A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development.

    Bashamboo A, Donohoue PA, Vilain E, et al.

    Human molecular genetics 2016; (25(16)):3446-3453 doi:10.1093/hmg/ddw186.

    PMID: 27378692
  6. 6

    GH successful treatment in a female with a de novo 46,XX,add(X)(p36),t(X;Y)(p36.3;p11.2), growth impairment and SHOX-haploinsufficiency.

    Maggio MC, Corsello G

    Italian journal of pediatrics 2019; (45(1)):100 doi:10.1186/s13052-019-0694-y.

    PMID: 31412912
  7. 7

    Ten cases with 46,XX testicular disorder of sex development: single center experience.

    Akinsal EC, Baydilli N, Demirtas A, et al.

    International braz j urol : official journal of the Brazilian Society of Urology 2017; (43(4)):770-775 doi:10.1590/S1677-5538.IBJU.2016.0505.

    PMID: 28379671
  8. 8

    Clinical and genetic analysis in males with 46,XX disorders of sex development: A reproductive centre experience of 144 cases.

    Chen T, Tian L, Wu F, et al.

    Andrologia 2019; (51(4)):e13232 doi:10.1111/and.13232.

    PMID: 30623467
  9. 9

    Very late presentation of a disorder of sex development.

    Martins JM, Fraga M, Miguens J, et al.

    Andrologia 2017; (49(10)) doi:10.1111/and.12831.

    PMID: 28493439

This page explains factors that can affect adult height in 46,XX testicular DSD for informational purposes only and does not replace medical advice. An endocrinology team should interpret growth, hormone tests, and bone age for your individual situation.

Get notified when new evidence is published on 46,XX testicular difference of sex development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.